US2005079182A1PendingUtilityA1
Immunogenic compositions of human papillomavirus and sera produced therefrom
Priority: Nov 30, 1984Filed: Sep 7, 2004Published: Apr 14, 2005
Est. expiryNov 30, 2004(expired)· nominal 20-yr term from priority
C12Q 1/708C12N 2710/20022Y10S435/948C07K 14/005
67
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A purified human papillomavirus gene selected from the group consisting of E1, E6-E7, Li, and L2, wherein said human papillomavirus is selected from the group consisting of HPV-2d, HPV-10b, HPV-14a, HPV-14b, HPV-15, HPV-17a, HPV-17b, HPV-19, HPV-20, HPV-21, HPV-22, HPV-23, HPV-24, HPV-28, HPV-29, HPV-31, HPV32, HPV-1P2 and HPV-IP4. Polypeptides encoded by these genes. The polypeptides can be used in immunogenic compositions.
Claims
exact text as granted — not AI-modified1 . A pharmaceutical composition for inducing remission of human papillomavirus (HPV) infection, comprising a. antibodies produced by immunizing a mammal with an immunogenic composition wherein said immunogenic composition comprises a polypeptide encoded by a DNA of a human papillomavirus, wherein said DNA is about 7,000 to about 8,000 base pairs, wherein said human papillomavirus is HPV-IP4, and wherein said polypeptide is encoded by a human papillomavirus gene selected from the group consisting of E1, E6, E7, L1 and L2; and b. a physiologically acceptable pharmaceutical vehicle.
Join the waitlist — get patent alerts
Track US2005079182A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.